Ligand validation:3U17

MPD: (4S)-2-METHYL-2,4-PENTANEDIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3U17_MPD_A_548	53%	76%	0.176	0.938	0.35	0.59	-	-	2	0	100%	1
3U16_MPD_A_548	70%	71%	0.12	0.938	0.35	0.74	-	-	2	0	100%	1
3O83_MPD_A_546	57%	78%	0.128	0.903	0.29	0.59	-	-	2	0	100%	1
3O84_MPD_A_546	38%	78%	0.188	0.888	0.25	0.62	-	-	0	0	100%	1
9D77_MPD_A_505	100%	87%	0.032	0.998	0.16	0.52	-	-	1	0	100%	1
9H8Q_MPD_B_602	100%	82%	0.039	0.988	0.35	0.44	-	-	3	0	100%	1
9MMI_MPD_B_301	100%	79%	0.04	0.983	0.3	0.56	-	-	4	0	100%	1
7Z6B_MPD_B_307	99%	74%	0.057	0.986	0.42	0.59	-	-	0	0	100%	1
7ZOB_MPD_F_202	99%	72%	0.056	0.983	0.44	0.65	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.